Anavex Life Sciences Corp (AVXL)
Net Income Growth
50.09%
TTM · Period ending:
AVXL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported50.09%period ending
Latest reported50.09%period ending
AVXL TTM Net Income YoY % (81.41% → 50.09%)
Year-over-year change
High-resolution chart · PNG
AVXL net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 50.0913% | |
| 27.6872% | |
| 14.0758% | |
| -7.8485% | |
| -15.994% | |
| -16.1279% | |
| -7.7302% | |
| 9.4791% | |
| 19.5963% | |
| 23.0252% | |
| 13.8064% | |
| 0.9856% | |
| -13.7509% | |
| -22.0235% | |
| -22.3071% | |
| -26.562% | |
| -41.206% | |
| -51.8457% | |
| -48.6223% | |
| -44.2464% | |
| -32.904% | |
| -17.4667% | |
| -13.628% | |
| -6.9704% | |
| 8.636% | |
| -6.2305% | |
| -19.3275% | |
| -40.7632% | |
| -57.4887% | |
| -29.7739% | |
| -41.3351% | |
| -29.6648% | |
| -13.4851% | |
| -30.7033% | |
| -3.1881% | |
| 8.6606% | |
| -9.0921% | |
| 13.7001% | |
| 8.8183% | |
| -21.7091% | |
| 17.4391% | |
| -17.8684% | |
| -22.0735% | |
| -6.5073% | |
| -253.1881% | |
| -247.8273% | |
| -333.3163% | |
| -207.249% | |
| -235.3544% | |
| 34.2404% | |
| 56.1359% | |
| 55.4472% | |
| 84.6507% | |
| 5.0192% | |
| 7.8842% | |
| -21.0741% | |
| -9.9665% | |
| 29.3708% | |
| 14.4786% | |
| 1.1354% | |
| -34.0651% | |
| -56.3104% | |
| -65.8514% | |
| -26.1605% | |
| -9.983% | |
| 6.917% | |
| 6.0242% | |
| -1.4041% | |
| -24.143% | |
| -92.8838% | |
| -109.6987% | |
| -243.2464% | |
| -917.0506% | |
| -1,491.9947% | |
| -8,906.7066% | |
| -6,088.2853% | |
| -615.1888% | |
| -89.3872% | |
| 80.1271% | |
| 81.4073% |